Reading "between the lines", in today's OXX Investor...

Reading "between the lines", in today's OXX Investor Presentation (quite impressive, to say the least)I stumbled upon this GEM on the section "Exploration and investment Philosophy" (page 8): ....."Acquire known resources with development potential (e.g Cornea)".......
I was stunned!!!!!
The Market, US SHAREHOLDRES of MOG, was led to believe that Cornea was (almost) a duster and price wise wrote it (almost, if not entirely) off, allowing for no value at all to the Cornea result....
Today, to my utter amazement I had to learn from OXX's Investor Presentation, same day as OXX's T.H, that Cornea is alive, COMMERCIAL and kicking!!!!!
Could it be, just "surmising", that the acquisition mentioned as the reason for OXX's T.H, is in fact the Acquisition of Cornea By OXX???? If Yes......Well.....I will not say anything before we see the details......BUT.....BUT......MOG Shareholders have every right to know: Why are OXX's shareholders (both companies controlled by Albers- PUBLIC COMPANIES nevertheless)are being told that Cornea is a Comercial Discovery, and we are still waiting for "some lab" results, while writing off (almost) Cornea's Commercial potentiality???

No more for the time being, no more until we see OXX's announcement, later today.....Then...Well then, we will have a lot to say.......